T cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis B

Background & Aims T cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) has been shown to influence autoimmune diseases; however, its function in viral infection has not been well-defined. We therefore investigated the expression and regulatory function of Tim-3 in natural killer...

Full description

Saved in:
Bibliographic Details
Published inJournal of hepatology Vol. 52; no. 3; pp. 322 - 329
Main Authors Ju, Ying, Hou, Nan, Meng, Jing, Wang, Xiaoyan, Zhang, Xiaoning, Zhao, Di, Liu, Ying, Zhu, Faliang, Zhang, Lining, Sun, Wensheng, Liang, Xiaohong, Gao, Lifen, Ma, Chunhong
Format Journal Article
LanguageEnglish
Published Kidlington Elsevier B.V 01.03.2010
Elsevier
Subjects
MNC
MFI
HDV
HBV
HIV
NKT
HGV
HCV
CHB
FLD
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background & Aims T cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) has been shown to influence autoimmune diseases; however, its function in viral infection has not been well-defined. We therefore investigated the expression and regulatory function of Tim-3 in natural killer (NK) cells in chronic Hepatitis B (CHB) infection. Methods Seventy-six CHB patients, 38 healthy controls, and 18 patients with fatty liver disease (FLD) were tested for Tim-3 expression on peripheral blood mononuclear cells (PBMCs) and in the liver tissue by flow cytometry and immunohistochemical stainning. The effects of HBV infection on Tim-3 expression in NK cells and the roles of Tim-3 in regulation of NK-cell function were also studied. Results There was a significant increase of Tim-3 expression in PBMCs, circulating NK cells and liver infiltrating lymphocytes (LILs) from CHB patients compared to that of healthy controls and FLD patients. Increased Tim-3 expression was also detected in NK92 cells that had been transfected with a HBV expression vector and NK cells isolated from the liver of HBV transgenic mice. Importantly, blockage of Tim-3 signaling with anti-Tim-3 antibodies or Tim-3-Fc fusion proteins resulted in an increased cytotoxicity for NK92 cells compared to HepG2 and HepG2.2.15 cells, as well as an elevated interferon-gamma (IFN-γ) production. Similarly, enhanced cytotoxicity was also observed in PBMCs or NK cells from CHB patients treated with the Tim-3 blockade ex vivo. Conclusion HBV infection can up-regulate Tim-3 expression in NK cells, which may in turn suppress NK-cell functions in CHB patients.
ISSN:0168-8278
1600-0641
DOI:10.1016/j.jhep.2009.12.005